Related Experiment Video

Updated: Jul 13, 2026

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

Imatinib for chronic myeloid leukaemia: a NICE mess

D Lim, J Muir

    Lancet (London, England)
    |December 14, 2001
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
    06:39

    Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

    Published on: October 3, 2018

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
    06:28

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

    Published on: November 10, 2023

    Related Experiment Videos

    Last Updated: Jul 13, 2026

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
    11:25

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

    Published on: April 1, 2015

    Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
    06:39

    Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

    Published on: October 3, 2018

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
    06:28

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

    Published on: November 10, 2023

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

    Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

    Articles linked to this work by shared authors, journal, and citation graph.

    Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study.

    ESMO open·2025

    Isolation of psychedelic-responsive neurons underlying anxiolytic behavioral states.

    Science (New York, N.Y.)·2024

    Impact of heteroresistance on treatment outcomes of people with drug-resistant TB.

    IJTLD open·2024

    Neuromodulator and neuropeptide sensors and probes for precise circuit interrogation in vivo.

    Science (New York, N.Y.)·2024

    Prefrontal cortex astroglia modulate anhedonia-like behavior.

    Molecular psychiatry·2023

    Clinicopathological correlation of oral candidiasis - Our experience in a tertiary centre over two decades.

    The Malaysian journal of pathology·2023

    Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

    Lancet (London, England)·2026

    Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.

    Lancet (London, England)·2026

    Risk of transmission of amyloid β pathology via transfused blood products.

    Lancet (London, England)·2026

    Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.

    Lancet (London, England)·2026

    Advances in γδ T Cells: Cutaneous Biology and Therapeutic Potential for Skin Neoplasms.

    The Journal of dermatology·2026

    Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.

    Apoptosis : an international journal on programmed cell death·2026

    Intersession reliability of transcranial magnetic stimulation measures of interhemispheric inhibition.

    Neuroscience·2026

    Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

    Frontiers in oncology·2026

    Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

    Nature reviews. Cancer·2026

    Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

    Clinical rheumatology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us